Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-87.94	-66.41	-35.33
Graham Fair Price	-25.25	6.75	9.03
PEG	215.35	0.18	-0.06
Price/Book	-53.74	-5.05	-3.28
Price/Cash Flow	-5.38	-41.58	-39.46
Prices/Earnings	-37.34	-3.80	-2.77
Price/Sales	366.57	267.68	57.37
Price/FCF	-5.38	-41.58	-39.46
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-967.36	-0.61	-0.06
Operating Margin	-305.76	-5.86	-1.45
ROA	29.15	-0.21	-0.29
ROE	0.30	0.33	11.94
ROIC	-0.48	-0.21	55.67
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.06	-61.88
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.13	0.06	-57.20
EPS QOQ	-0.49	0.21	-56.45
FCF QOQ	0.39	-0.03	-92.15
Revenue QOQ	2.00	-0.77	-61.67
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	118.74	415.96	250.32
Days Sales Outstanding (DSO)	147.02	523.85	256.30
Inventory Turnover	0.76	0.22	-71.45
Debt/Capitalization	7.52	2.99	-60.20
Quick Ratio	0.38	0.56	47.43
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	-3.49	-2.47	29.35
Cash	0.04	0.24	480.90
Capex	-0.04	-0.02	55.92
Free Cash Flow	-0.29	-0.30	-3.08
Revenue	0.20	0.05	-76.72
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.75	1.18	58.63
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-9.11	-15.76	-72.93
Naive Interpretation	Member

06 - Financial Health · Bad

Rating